Phase 1/2Recruiting

Digital STEADI Efficacy

Randomized Control Trial to Test the Efficacy of the Digital STEADI Program.

Sponsor
Friendi.fi Corporation (Industry)
Enrolment
300 planned
Conditions
Fall; Mild Cognitive Impairment (MCI); Aging
Interventions
Digital STEADI-1; STEADI Standard of Care; Digital STEADI-2; Attentional control
Ages
adults, older adults
Registry
NCT07852650

From the registry

The aging of the U.S. population, combined with health care workforce shortages and insufficient access to effective fall prevention and exercise programs, has contributed to a high burden of fall-related injuries in older adults, especially in those with Mild Cognitive Impairment (MCI), a precursor of Alzheimer's dementia (AD) and related dementias (ADRD). There is an urgent need for scalable, evidence-based interventions that can be delivered efficiently in the home setting. This study aims to evaluate the efficacy and impact of a comprehensive digital fall prevention program (Digital STEADI) delivered through a technology platform with two conversational agents that leverage generative artificial intelligence (gen-AI) with human oversight to increase program access, enhance adherence to clinical fall prevention protocols and best practices, and reduce fall risk among community-dwelling older adults.

Primary outcomes

  • Change from baseline fear of falling as measured by the Fall Efficacy Scale International (FES-I)
Full record on ClinicalTrials.gov